Showing results (431-440 of 471) with videos related to

Sort By:
Pageof 48
Journal of Medicinal Chemistry|November 13, 2007
Synthesis and nicotinic acetylcholine receptor binding properties of bridged and fused ring analogues of epibatidineF Ivy Carroll, T Philip Robinson, Lawrence E Brieaddy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2001
High-dose chemotherapy for ovarian carcinoma: long-term results from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT)J A Ledermann, R Herd, D Maraninchi, et al.
La Nouvelle Presse Medicale|December 17, 1979
[Epstein-Barr virus associated Burkitt's lymphoma in a French child (author's transl)]G Lenoir, T Philip, G W Bornkamm, et al.
Presse Medicale (Paris, France : 1983)|June 11, 1988
[Hemoperfusion on charcoal and hemodialysis in acute poisoning caused by methotrexate]D Frappaz, E Bouffet, P Cochat, et al.
Cancer Genetics and Cytogenetics|September 1, 1983
Catalase determination in various etiologic forms of Wilms' tumor and gonadoblastomaC Junien, C Turleau, G M Lenoir, et al.
The New England Journal of Medicine|December 7, 1995
Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphomaT Philip, C Guglielmi, A Hagenbeek, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 14, 2011
Studies to further investigate the inhibition of human liver microsomal CYP2C8 by the acyl-β-glucuronide of gemfibrozilS M Jenkins, T Zvyaga, S R Johnson, et al.
The New England Journal of Medicine|June 11, 1987
High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphomaT Philip, J O Armitage, G Spitzer, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 7, 2006
[Understanding nephroblastoma. Information dedicated to parents and relatives]S Brusco, C Bergeron, L Boccon-Gibod, et al.
The New England Journal of Medicine|May 1, 1998
Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma. Groupe Français d'ImmunothérapieS Negrier, B Escudier, C Lasset, et al.
Pageof 48